Cited by 116Cardiovascular Function and Risk FactorsBlood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

The DOI matches its Crossref record.

Left ventricular hypertrophy as a risk factor in arterial hypertension

Kannel, W. B.·1992·European Heart Journal

DOI 10.1093/eurheartj/13.suppl_d.82

Open this paper in CoChat — free account

Abstract

Data on the evolution and prognostic implications of left ventricular hypertrophy (LVH) determined by ECG, chest X-ray and echocardiogram in the Framingham Study are reviewed. Echocardiographic examination provides the most sensitive and specific measure of left ventricular hypertrophy, providing a quantitative evaluation of the anatomical condition. Chest X-ray evaluation is also more sensitive than the ECG, but less specific than the echocardiogram. When ECG-LVH is present, X-ray and echocardiographic LVH are often found; but, when negative, the ECG clearly does not exclude anatomical LVH. The incidence of each variety of LVH increases with age, weight and blood pressure. Although it may also appear following coronary heart disease (CHD), valvular deformity and congenital cardiac defects, the former are the major determinants of LVH in the general population. Each contributes independently to the occurrence of LVH. LVH has emerged as a powerful non-invasive indicator of increased vulnerability to the occurrence of major cardiovascular disease outcomes in hypertension. It appears that X-ray and echocardiographic LVH measure anatomical hypertrophy, whereas the ECG variety is also indicative of ischaemic myocardial involvement when repolarization abnormality is present. Hypertension clearly predisposes to both anatomical and ECG-LVH which cannot be taken as an incidental compensatory feature since at any blood pressure those with ECG-LVH, X-ray or echo LVH are distinctly more prone to cardiovascular sequelae. ECG-LVH carries a greater risk than anatomical (X-ray) LVH. ECG-LVH with repolarization abnormality is more dangerous than that with voltage alone. The latter appears to reflect chiefly the severity and duration of accompanying hypertension. There are no cardiovascular sequelae unique to either anatomical or ECG-LVH, but the ECG variety carries a substantially greater risk of cardiovascular events, particularly for coronary disease. Also, on cross-classification each is found to add to the risk of the other with ECG-L VH adding more to the risk than the concomitant anatomical hypertrophy. The combination confers the highest risk. Risk ratios associated with ECG-LVH are substantial and greatest for cardiac failure and stroke, but CHD is the commonest and most lethal sequela. ECG-LVH carries a risk as great as ECG-MI (ECG-myocardial infarction) and predisposes strongly to sudden death. Anatomical and ECG-LVH appear to make the myocardium more irritable, generating dangerous arrhythmias. Once an MI has occurred, ECG-LVH or X-ray LVH each independently contributes to recurrences or other adverse outcomes. LVH is reversible, the anatomical variety more so than the ECG, and the reversion of anatomical LVH appears to confer greater benefit than improvement of the ECG version.

Integrity signals

Registry

Crossref · 10.1093/eurheartj/13.suppl_d.82

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients
Solomon, S. D., Anavekar, N. S., Skali, H., McMurray, J. J. V., Swedberg, K. B., Yusuf, S., Granger, C. B., Michelson, E. L., Wang, D., Pocock, S., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.561423 · Cited by 873
Renal Sympathetic Denervation Reduces Left Ventricular Hypertrophy and Improves Cardiac Function in Patients With Resistant Hypertension
Brandt, M. C., Mahfoud, F., Reda, S., Schirmer, S. H., Erdmann, E., Böhm, M., & Hoppe, U. C. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.034 · Cited by 501
Cardiac and vascular pathophysiology in hypertension
Mayet, J., & Hughes, A. (2003) · Heart · doi:10.1136/heart.89.9.1104 · Cited by 321
Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans
Rossi, M. A. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816070-00018 · Cited by 285
Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension
Brown, D. W., Giles, W. H., & Croft, J. B. (2000) · American Heart Journal · doi:10.1067/mhj.2000.111112 · Cited by 242
Left Ventricular Hypertrophy and QT Dispersion in Hypertension
Mayet, J., Shahi, M., McGrath, K., et al. (1996) · Hypertension · doi:10.1161/01.hyp.28.5.791 · Cited by 171
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values
Bombelli, M., Facchetti, R., Carugo, S., Madotto, F., Arenare, F., Quarti‐Trevano, F., Capra, A., Giannattasio, C., Dell’Oro, R., Grassi, G. M., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328330b845 · Cited by 170
Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive
Greenwood, J. P., Scott, E. M., Stoker, J. B., & Mary, D. A. S. G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01600-x · Cited by 161
Pharmacological Approaches to the Prevention of Restenosis Following Angioplasty
HERRMAN, J. P., Hermans, W. R. M., Vos, J., & Serruys, P. W. J. C. (1993) · Drugs · doi:10.2165/00003495-199346010-00003 · Cited by 150
Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave. The Copenhagen City Heart Study
Larsen, C. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2774 · Cited by 139
Does Renal Dysfunction Predict Mortality After Acute Stroke?
MacWalter, R. S., Wong, S., Wong, K., et al. (2002) · Stroke · doi:10.1161/01.str.0000016344.49819.f7 · Cited by 135
“Admission glucose 6 mmol/L, n (%) 160 (16) 160 (16) 177 (17) 201 (19) 337 (17) 361 (18)”
Calcitriol Regresses Cardiac Hypertrophy and QT Dispersion in Secondary Hyperparathyroidism on Hemodialysis
Kim, H. W., Park, C. W., Shin, Y. S., Kim, Y. S., Shin, S. J., Kim, Y., Choi, E. J., Chang, Y. S., & Bang, B. K. (2005) · Nephron Clinical Practice · doi:10.1159/000088295 · Cited by 134
Relationship Between Central Sympathetic Drive and Magnetic Resonance Imaging–Determined Left Ventricular Mass in Essential Hypertension
Burns, J., Sivananthan, M. U., Ball, S. G., Mackintosh, A. F., Mary, D. A. S. G., & Greenwood, J. P. (2007) · Circulation · doi:10.1161/circulationaha.106.668863 · Cited by 122
Effects of 7 Years of Growth Hormone Replacement Therapy in Hypopituitary Adults
Chrisoulidou, A., Beshyah, S., Rutherford, O. M., Spinks, T. J., Mayet, J., Kyd, P., Anyaoku, V., Haida, A., Ariff, B., Murphy, M. C., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6910 · Cited by 127
“Left ventricular hypertrophy is a powerful predictor of morbidity and mortality in the population (45).”
Background
A comparison of MRI and echocardiography in hypertrophic cardiomyopathy.
Devlin, A. M., Moore, N. R., & Ostman-Smith, I. (1999) · British Journal of Radiology · doi:10.1259/bjr.72.855.10396215 · Cited by 86
Hypertension: Reflections on Risks and Prognostication
Kannel, W. B. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.02.006 · Cited by 86
Self-citation
Determinants of Discrepancies in Detection and Comparison of the Prognostic Significance of Left Ventricular Hypertrophy by Electrocardiogram and Cardiac Magnetic Resonance Imaging
Bachárová, L., Chen, H., Estes, E. H., Mateašík, A., Bluemke, D. A., Lima, J. A. C., Burke, G. L., & Soliman, E. Z. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.11.037 · Cited by 79
Arterial hypertension and cardiac arrhythmias
Hennersdorf, M., & Strauer, B. E. (2001) · Journal of Hypertension · doi:10.1097/00004872-200102000-00002 · Cited by 72
Correlates and outcomes of preserved left ventricular systolic function among older adults hospitalized with heart failure
Ahmed, A., Roseman, J. M., Duxbury, A. S., Allman, R. M., & DeLong, J. F. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124058 · Cited by 68
Predictors of One-Year Disability and Death in Chinese Hospitalized Women after Ischemic Stroke
Kong, F., Tao, W., Hao, Z., & Liu, M. (2009) · Cerebrovascular Diseases · doi:10.1159/000267852 · Cited by 67
Telmisartan: A Different Angiotensin II Receptor Blocker Protecting a Different Population?
Burnier, M. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700602 · Cited by 69
The incidence and risk factors for new onset atrial fibrillation in the PROSPER study
Macfarlane, P. W., Murray, H. M., Sattar, N. A., Stott, D. J., Ford, I., Buckley, B. M., Jukema, J. W., Westendorp, R. G. J., & Shepherd, J. (2011) · EP Europace · doi:10.1093/europace/eur016 · Cited by 65
Report of the Task Force on Research in Heart Failure.
Lenfant, C. J. M. (1994) · Circulation · doi:10.1161/01.cir.90.3.1118 · Cited by 64
Ventricular Arrhythmias in Adult Aortic Stenosis
Sorgato, A., Faggiano, P. M., Aurigemma, G. P., et al. (1998) · CHEST Journal · doi:10.1378/chest.113.2.482 · Cited by 62
Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures
Landzberg, B. R., Frishman, W. H., & Lerrick, K. (1997) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(97)80034-5 · Cited by 61
Hypertension and arrhythmia: blood pressure control and beyond
Yı́ldı́rı́r, A. (2002) · EP Europace · doi:10.1053/eupc.2002.0227 · Cited by 58
“However, beyond a critical value it significantly increases the morbidity and mortality of the patients, particularly of sudden cardiac death([19,20]).”
Background
New standards in hypertension and cardiovascular risk management: focus on telmisartan
Galzerano, D. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s7857 · Cited by 53
Cardiothoracic ratio and relative heart volume as predictors of coronary heart disease mortality. The Whitehall study 25 year follow-up
Hemingway, H. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0862 · Cited by 47
Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic
Cramariuc, D., & Gerdts, E. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2016.1186542 · Cited by 48
“ciated with a 5–9-fold increased rate of sudden cardiac death during 36 years’ follow-up [44].”
Background
Increased Prevalence of Cardiac Arrhythmias and Transient Episodes of Myocardial Ischemia in Hypertensives With Left Ventricular Hypertrophy but Without Clinical History of Coronary Heart Disease
Novo, S. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00127-1 · Cited by 44
Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality
Kaplinsky, E. (1994) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877223 · Cited by 45
“Thus, patients with LVH are at greater risk to die from a heart attack [9,53].”
Background
Restenosis—an open file
Gottsauner‐Wolf, M., Moliterno, D. J., Lincoff, A. M., et al. (1996) · Clinical Cardiology · doi:10.1002/clc.4960190505 · Cited by 41
Effects of 5 years of growth hormone (GH) replacement therapy on cardiac parameters and physical performance in adults with GH deficiency
Cenci, M. C. P., Soares, D. V., Spina, L. D. C., Brasil, R. R. L. O., Lobo, P. M., Mansur, V. A., Gold, J., Micmacher, E., Vaisman, M., & Conceição, F. L. (2009) · Pituitary · doi:10.1007/s11102-009-0182-2 · Cited by 34
QT dispersion in athletic left ventricular hypertrophy
Mayet, J., Kanagaratnam, P., Shahi, M., et al. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70222-x · Cited by 26
Early origins of heart disease: Low birth weight and the role of the insulin‐like growth factor system in cardiac hypertrophy
Wang, K. C. W., Botting, K. J., Padhee, M., Zhang, S., McMillen, I. C., Suter, C. M., Brooks, D. A., & Morrison, J. L. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2012.05743.x · Cited by 26
Left ventricular hypertrophy in association with cognitive impairment: a systematic review and meta-analysis
Georgakis, M. K., Synetos, A. G., Mihas, C. C., Karalexi, M. A., Tousoulis, D. M., Seshadri, S. S., & Petridou, E. T. (2017) · Hypertension Research · doi:10.1038/hr.2017.11 · Cited by 27
Contrasting effect of exercise and angiotensin II hypertension on in vivo and in vitro cardiac angiogenesis in rats
Belabbas, H., Zalvidéa, S., Casellas, D., et al. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00014.2008 · Cited by 24
Multivariate associates of QT interval parameters in diabetic patients with arterial hypertension: importance of left ventricular mass and geometric patterns
Salles, G. F., Cardoso, C. R. L., & Deccache, W. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001590 · Cited by 23
Morbimortalidad cardiovascular y patrones geométricos del ventrículo izquierdo en pacientes hipertensos atendidos en atención primaria
Tovillas-Morán, F. J., Zabaleta‐del‐Olmo, E., Dalfó-Baqué, A., Cosculluela, M. V., Galcerán, J., & Coca, A. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)70367-7 · Cited by 20
Is Carotid Artery Intima-Media Thickening a Reliable Marker of Early Atherosclerosis?
Mayet, J., Stanton, A. V., Chapman, N., Foale, R. A., Hughes, A. D., & Thom, S. (2002) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670200900202 · Cited by 19
Spectrum of cardiac abnormalities associated with long QT in stroke survivors
Wong, K., McSwiggan, S., Kennedy, N., et al. (2005) · Heart · doi:10.1136/hrt.2004.045187 · Cited by 17
“8 Indeed, if LVH regresses fully the risk appears to return to that of someone without LVH at all.”
Background
Interrelationships between Salt and Fish Oil in Stroke-Prone Spontaneously Hypertensive Rat
Vaskonen, T., Laakso, J. T., Mervaala, E. M. A., Sievi, E., & Karppanen, H. (1996) · Blood Pressure · doi:10.3109/08037059609062127 · Cited by 17
Hypertension and hyperparathyroidism are associated with left ventricular hypertrophy in patients on hemodialysis
Al‐Hilali, N., Hussain, N., Ataia, A., et al. (2009) · Indian Journal of Nephrology · doi:10.4103/0971-4065.59337 · Cited by 16
Cardiovascular Morbidity and Mortality and Left Ventricular Geometric Patterns in Hypertensive Patients Treated in Primary Care
Tovillas-Morán, F. J., Zabaleta‐del‐Olmo, E., Dalfó-Baqué, A., Cosculluela, M. V., Galcerán, J., & Coca, A. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)71553-1 · Cited by 15
Amlodipine - a third generation dihydropyridine calcium antagonist
Steffen, H. (1999) · Journal of clinical and basic cardiology · Cited by 14
Left ventricular hypertrophy: an ECG-based study of prevalence and risk factors in a multiethnic population
Taki, H., Tuomilehto, J. O., Zimmet, P., Tamošiūnas, A., Kowlessur, S., Magliano, D. J., Shaw, J. E., Söderberg, S., & Nilsson, U. A. (2023) · Open Heart · doi:10.1136/openhrt-2023-002495 · Cited by 13
Medical therapies for the prevention of restenosis after percutaneous coronary interventions
Frishman, W. H., Chiu, R. C. W., Landzberg, B. R., & Weiss, M. B. (1998) · Current Problems in Cardiology · doi:10.1016/s0146-2806(98)80002-9 · Cited by 13
Microalbuminuria, Pulse Pressure, Left Ventricular Hypertrophy, and Myocardial Ultrasonic Tissue Characterization In Essential Hypertension
Bello, V. D., Pedrinelli, R., Giorgi, D., et al. (2001) · Angiology · doi:10.1177/000331970105200303 · Cited by 13
Left Ventricular Structure and Function in Previously Untreated Hypertensive Patients: The Importance of Blood Pressure, the Nocturnal Blood Pressure Dip and Heart Rate
Mayet, J., Shahi, M., Hughes, A. D., et al. (1995) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679500200312 · Cited by 13
A potential role of caspase recruitment domain family member 9 (Card9) in transverse aortic constriction-induced cardiac dysfunction, fibrosis, and hypertrophy
Peterson, M. R., Getiye, Y., Bosch, L., Sanders, A., Smith, A., Haller, S., Wilson, K., Thomas, D. P., & He, G. (2020) · Hypertension Research · doi:10.1038/s41440-020-0507-0 · Cited by 12
Effects of valsartan and enalapril on regression of left ventricular hypertrophy in patients with mild to moderate hypertension: A randomized, double-blind study
Nalbantgil, S., Yılmaz, H., Gurun, C., et al. (2000) · Current Therapeutic Research · doi:10.1016/s0011-393x(00)80002-8 · Cited by 12
Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?
Sheridan, KINGSBURY, M. P., & Flores (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00871.x · Cited by 11
How much echo left ventricular hypertrophy would be missed in diabetics by applying the Losartan Intervention For Endpoint Reduction electrocardiogram criteria to select patients for angiotensin receptor blockade?
Dawson, A., Rana, B. S., Pringle, S. D., Donnelly, L. A., Morris, A. D., & Struthers, A. D. (2004) · Journal of Hypertension · doi:10.1097/01.hjh.0000125408.50839.b8 · Cited by 11
Does a prolonged QT peak identify left ventricular hypertrophy in hypertension?
Wong, K., Lim, P. O., Wong, S. Y. S., et al. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00473-4 · Cited by 10
Disproportionate Pregnancy-Induced Myocardial Hypertrophy in Women With Essential Hypertension
Bazan, S. G. Z., Borges, V. T. M., Martín, L. C., et al. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt023 · Cited by 10
A machine learning-based score for precise echocardiographic assessment of cardiac remodelling in hypertensive young adults
Alsharqi, M., Lapidaire, W., Iturria‐Medina, Y., Xiong, Z., Williamson, W., Mohamed, A. B., Tan, C., Kitt, J., Burchert, H. H., Fletcher, A. J., et al. (2023) · European Heart Journal - Imaging Methods and Practice · doi:10.1093/ehjimp/qyad029 · Cited by 9
“30 Although signs of left ventricular hypertrophy secondary to hypertension has been well studied and linked with poor prognosis later in life, 36 wall thickness variables and left ventricular mass contributions were not as significant as the functional diastolic variables in our model.”
Result
The Effects on Cardiac Arrhythmias of Antihypertensive Therapy Causing Regression of Left Ventricular Hypertrophy
Mayet, J. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00041-1 · Cited by 9
Markers of electrical instability in hypertensive patients with and without ventricular arrhythmias. Are they useful in identifying patients with different risk profiles?
Facchini, M., Malfatto, G., Ciambellotti, F., et al. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018060-00015 · Cited by 9
Morbilidad y mortalidad cardiovascular y criterios electrocardiográficos de hipertrofia ventricular izquierda en pacientes hipertensos en atención primaria
Tovillas-Morán, F. J., Vilaplana-Cosculluela, M., Zabaleta‐del‐Olmo, E., et al. (2010) · Medicina Clínica · doi:10.1016/j.medcli.2010.01.034 · Cited by 8
Cardiac evaluation for simultaneous pancreas-kidney transplantation and incidence of cardiac perioperative complications: preliminary study
Fossati, N., Meacci, L., Amorese, G., et al. (2004) · Transplantation Proceedings · doi:10.1016/j.transproceed.2004.02.036 · Cited by 8
Determinanten des paroxysmalen Vorhofflimmerns bei Patienten mit arterieller Hypertonie
Hennersdorf, M., Hafke, G. J., Steiner, S., Dierkes, S., Jansen, A., Perings, C. A., & Strauer, B. E. (2003) · Zeitschrift für Kardiologie · doi:10.1007/s00392-003-0924-5 · Cited by 8
A Simple Method for Assessing the Regression or Progression of Ventricular Hypertrophy in the Growing Child and Adult: the Value of Left Ventricular Wall-to-cavity Ratios
Östman-Smith, I. (2001) · European Journal of Echocardiography · doi:10.1053/euje.2000.0053 · Cited by 7
HYPERTENSION AND CORONARY ARTERY DISEASE
Srikanthan, V. S., & Dunn, F. G. (1997) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70572-1 · Cited by 6
Sympathetic Nervous System Activation in Pathogenesis of Development of Essential Hypertension and Its Role in Target-Organs Damage in Young and Middle Aged Adults: the Cardioprotective Capabilities of Bisoprolol
Ostroumova, O. D., Кочетков, А. И., Guseva, T. F., et al. (2018) · Kardiologiia · doi:10.18087/cardio.2018.3.10100 · Cited by 6
“Особое внимание уделяется ГЛЖ, поскольку показано, что она служит предиктором сердечно-сосудистой заболеваемости и смертности, в частности, на фоне нее риск развития ишемической болезни сердца и мозгового инсульта возрастает в 3 раза, ХСН – в 7 раз [18].”
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis
Giollo, A., Cioffi, G., Ognibeni, F., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.676076 · Cited by 6
Randomised, double-blind, placebo-controlled clinical trial investigating the effects of inorganic nitrate in hypertension-induced target organ damage: protocol of the NITRATE-TOD study in the UK
Lau, C. W. Z., Hamers, A. J. P., Rathod, K. S., Shabbir, A., Cooper, J. A., Primus, C., Davies, C., Mathur, A., Moon, J., Kapil, V., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034399 · Cited by 6
Ethnic differences in carotid and left ventricular hypertrophy
Stanton, A. V., Mayet, J., Chapman, N., et al. (2002) · Journal of Hypertension · doi:10.1097/00004872-200203000-00031 · Cited by 6
Morbilidad cardiovascular y su relación con la hipertrofia ventricular izquierda de una cohorte de pacientes hipertensos: estudio Gòtic
Tovillas, F. J., Dalfó, A., Lecumberri, S. R., Sisó‐Almirall, A., Senar, E., & Miracle, M. (2001) · Atención Primaria · doi:10.1016/s0212-6567(01)70382-4 · Cited by 6
Gender-age features of cardiac electrophysiological changes IN patients with arterial hypertension.
Gimayev, R. K., Рузов, В. И., Разин, В. А., et al. (2009) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2009-15-1-57-64 · Cited by 5
High sympathetic tone in development of the left ventricle hypertrophy and beta-blockers for regression
Ostroumova, O. D., Кочетков, А. И., Вадимовна, Л. М., & Евгеньевна, П. Е. (2018) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2018-9-77-88 · Cited by 5
Influence of chronic hormone replacement therapy on left ventricular mass and serum-ACE activity
Manhem, K., Ghanoum, B., Johansson, M. C., Milsom, I., & Gustafsson, H. (2010) · Blood Pressure · doi:10.3109/08037051.2010.488050 · Cited by 4
Differential Suppression of Pressure-Overload Cardiac and Aortic Hypertrophy in Rats by Angiotensin-Converting Enzyme Inhibitors
Wang, D., Kakizoe, E., Kobayashi, Y., Shimoura, K., & Okunishi, H. (1999) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.80.333 · Cited by 4
Left ventricular hypertrophy, cardiac imaging and cardiac electric activity
Gatzka, C. D. (2002) · Journal of Hypertension · doi:10.1097/00004872-200211000-00013 · Cited by 4
Reduced left ventricular hypertrophy in type 1 diabetic patients with end-stage renal failure. A comparison between groups investigated 1977-80 and 1991-93.
Bech‐Hanssen, O., Wallentin, I., Larsson, O., et al. (1996) · PubMed · Cited by 3
Acute kidney injury in patients with cerebrovascular stroke and its relationship to short-term mortality
Hamed, S. A., Youssef, A., Tohamy, A., et al. (2015) · International Research Journal of Medicine and Medical Sciences · Cited by 2
ECG Abnormalities and Arterial Stiffness by HIV Status among High-Risk Populations in Rakai, Uganda: A Pilot Study
Enriquez, R., Ssekubugu, R., Kigozi, G., Nabukalu, D., Marrone, G., Rautiainen, S., Gigante, B., Reynolds, S. J., Nalugoda, F. K., Chang, L. W., et al. (2021) · Global Heart · doi:10.5334/gh.1015 · Cited by 2
Role of echocardiography in primary care medicine. Controversies in hypertension, atrial fibrillation, stroke, and endocarditis.
Amidon, T. M., Chou, T. M., Kee, L. L., & Foster, E. (1996) · Europe PMC (PubMed Central) · Cited by 2
A coronary organic stenosis distal to severe, ergonovine induced spasm: decision making
Romagnoli, E., Niccoli, G., & Crea, F. (2005) · Heart · doi:10.1136/hrt.2004.058560 · Cited by 2
ARTERIAL HYPERTENSION IN THE PRESENCE OF OVERWEIGHT AND OBESITY. THE CAPABILITIES OF AMLODIPINE AND LISINOPRIL COMBINATION. PART 1. FEATURES OF THE DAILY PROFILE OF BLOOD PRESSURE AND HEART DAMAGE AS A TARGET ORGAN IN PATIENTS WITH ARTERIAL HYPERTENSION IN COMBINATION WITH OVERWEIGHT AND OBESITY
Ostroumova, O. D., Кочетков, А. И., Kopchjonov, I. I., et al. (2017) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2017-13-5-693-698 · Cited by 2
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis
Cioffi, G., Viapiana, O., Orsolini, G., Ognibeni, F., Dalbeni, A., Gatti, D., Adami, G., Fassio, A., Rossini, M., & Giollo, A. (2021) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14082 · Cited by 2
ARTERIAL HYPERTENSION ASSOCIATED WITH METABOLIC SYNDROME: FOCUS ON DAILY PROFILES OF CENTRAL AORTIC PRESSURE AND VASCULAR STIFFNESS
Panchenkova, L. A., Andreeva, L. A., Ахмедовна, Х. Х., et al. (2016) · Eurasian heart journal · doi:10.38109/2225-1685-2016-3-6-12 · Cited by 2
Calcium Channel Blockers
Hughes, A. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00021-9 · Cited by 2
Pressão de pulso obtida por monitorização residencial da pressão arterial e sua relação com o índice de massa do ventrículo esquerdo
Marco, A. D., Feitosa, A. D. M., Gomes, M. M., et al. (2007) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2007000100015 · Cited by 2
Aerobic Exercise Improves Cardiac Hypertrophy Through the RAF/MEK/ERK Complex Pathway in the Experimental Model of Obesity Induced by a High Fat/Fructose Diet in Rats
Oghbavi, S., & Shariati, M. (2025) · Jentashapir Journal of Cellular and Molecular Biology · doi:10.5812/jjcmb-164376 · Cited by 1
“Several studies have shown that intense EX can lead to increased left ventricular wall thickness and chamber size, considered pathological changes resulting from excessive training (10).”
ASSESMENT OF CLINICAL EFFECTIVENESS OF LOSARTAN AND AMLODIPINE IN HYPERTENSIVE PATIENT WITH LEFT VENTRICULAR HYPERTROPHY
Hameed, J., Rutuparna, P., Merin, D., et al. (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i5.16928 · Cited by 1
Prevalence and long-term prognostic implications of prolonged QRS duration in left ventricular hypertrophy: a population-based observational cohort study
Rankinen, J., Haataja, P., Lyytikäinen, L., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-053477 · Cited by 1
"Reabilitação Cardiovascular:Diminui a mortalidade e mantém a qualidade de vida, em doentes isquémicos, 4 anos após".
Azevedo, N. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/v3cw-t127 · Cited by 1
Progress in Interventional Cardiology
Talley, J. D. (1995) · Journal of Interventional Cardiology · doi:10.1111/j.1540-8183.1995.tb00586.x · Cited by 1
Associação da disfunção diastólica de origem hipertensiva com a atividade simpática cardíaca e periférica
de Souza, S. B. P. C. (2011) · doi:10.11606/t.5.2011.tde-01122011-103904
Bluthochdruck und Herzrhythmusstörungen - eine gefährliche Kombination
Strohmer, B. (2009) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Respuesta hipertensiva al esfuerzo y alteraciones cardiovasculares.
Aracil, B., & Manuel, R. (2008) · TDX (Tesis Doctorals en Xarxa)
Fragmented QRS and Left Ventricular Geometry in Hypertensive Patients
Bekar, L., & Celebi, S. A. (2013) · Koşuyolu Heart Journal · doi:10.5578/kkd.4653
“Bunun sonucunda oluşan kardiyak fi brozis ise sol ventrikül disfonksiyonu, aritmiler ve ani kardiyak ölüm gibi birçok klinik durumun gelişmesinde anahtar süreci oluşturur(21,22).”
Background
Effect of antihypertensive treatment on the prevalence of ventricular arrhythmias among patients with isolated systolic hypertension without left ventricular hypertrophy
Gürgün, C., Nalbantgil, S., Nalbantgil, İ., et al. (2002) · Current Therapeutic Research · doi:10.1016/s0011-393x(02)80004-2
Different Effects of Temocapril and Cadralazine on Electrocardiographic Voltages and Left Ventricular Mass in Patients with Essential Hypertension.
Tomita, S., Takata, M., Yasumoto, K., et al. (1999) · Japanese Heart Journal · doi:10.1536/jhj.40.55
ST-Segment Elevation in Electrocardiogram Lead aVR
Zema, M. J. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.07.060
Waist Circumference May be More Important than Body Mass Index (BMI) in Determinants of Left Ventricular Mass in Korean Hypertensive Patients
Lim, Y. H., Park, B. H., Kim, S. Z., et al. (2007) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2007.31.2.130
Allopurinol regresses left ventricular hypertrophy in patients with type 2 diabetes
Szwejkowski, B. R. (2014)
Effects of valsartan and nebivolol on blood pressure, QT dispersion and left ventricular hypertrophy in hypertensive patients Hipertansif hastalarda valsartan ve nebivololun, kan basinci, QT dağilimi ve sol ventrikül hipertrofisi üzerine etkileri
Negrea, L. A., & Bolboaca, S. D. (2010)
Breyting á tíðni þykknunar vinstri slegils og horfur, samanburður milli karla og kvenna 1967-1992 : hóprannsókn Hjartaverndar
Thrainsdottir, I. S., Hardarson, T., Þorgeirsson, G., et al. (2000) · Hirsla (Landspítali University Hospital)
Associação da disfunção diastólica de origem hipertensiva com a atividade simpática cardíaca e periférica
Paulo, S., de Cardiologia, P., & Consolim‐Colombo, F. M. (2011)

Authors: Kannel, W. B.
Affiliations: Boston University (US)
Corresponding author: Kannel, W. B.
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 1992-09-02
Volume: 13
Issue: suppl D
Pages: 82-88
ISSN: 0195-668X (ISSN-L)
1522-9645
DOI: 10.1093/eurheartj/13.suppl_d.82
OpenAlex: W2055676061
Cited by: 116
References: 0
Citations by year: 2025: 1 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 2 · 2014: 3 · 2013: 2 · 2012: 3
FWCI: 1.83
Type: journal article
Language: en
Open access: closed
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (N01-HV-92922, N01-HV52971)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords: left ventricular hypertrophy, hypertension, cardiovascular risk factors, coronary artery disease, sudden death, heart failure, stroke, Framingham Heart Study, hypertension prognosis, myocardial ischemia, cardiac arrhythmias
MeSH terms: Coronary Disease, Echocardiography, Electrocardiography, Female, Humans, Hypertension, Male, Middle Aged, Prognosis, Risk Factors, Ventricular Function, Left, Hypertrophy, Left Ventricular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Left ventricular hypertrophy as a risk factor in arterial hypertension

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks